Determination of imatinib mesylate and related compounds by field amplified sample stacking with large volume sample injection capillary electrophoresis

Journal of Pharmaceutical and Biomedical Analysis

Volumn 70, Issue , 2012, Pages 26-31

  Li, Jian ^a   Huang, Yifei ^a   Huang, Lei ^a   Ye, Lei ^a   Zhou, Zhou ^a   Xiang, Guangya ^a   Xu, Li ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Capillary electrophoresis; Drug quality control; Field amplified sample stacking; Imatinib mesylate; Large volume sample injection

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 4 CHLOROMETHYL N [4 METHYL 3 [[4 (PYRIDIN 3 YL)PYRIMIDIN 2 YL]AMINO]PHENYL]BENZAMIDE; BENZAMIDE DERIVATIVE; DRUG METABOLITE; HYDROCHLORIC ACID; IMATINIB; METHANOL; N NORIMATINIB; SOLVENT; UNCLASSIFIED DRUG;

ACIDITY; AQUEOUS SOLUTION; ARTICLE; BATCH PROCESS; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DRUG QUALITY; ELECTRIC POTENTIAL; HYDRODYNAMICS; INTERMETHOD COMPARISON; ONLINE ANALYSIS; PH; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SEPARATION TECHNIQUE; SOLVENT EFFECT; STANDARD;

ANTINEOPLASTIC AGENTS; BETA-CYCLODEXTRINS; BUFFERS; DRUG CONTAMINATION; ELECTROPHORESIS, CAPILLARY; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; PHOSPHATES; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLVENTS;

EID: 84866254712     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.05.010     Document Type: Article

References (28)

1. Dagher R., Cohen M., Williams G., Rothmann M., Gobburu J., Robbie G., Rahman A., Chen G., Staten A., Griebel D., Pazdur R. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin. Cancer Res. 2002, 8:3034-3038.
2. Cohen M.H., Williams G., Johnson J.R., Duan J., Gobburu J., Rahman A., Benson K., Leighton J., Kim S.K., Wood R., Rothmann M., Chen G., Maung K., Staten A.M., Pazdur R. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin. Cancer Res. 2002, 8:935-942.
3. Garcia-Manero G., Talpaz M., Kantarjian H.M. Current therapy of chronic myelogenous leukemia. Intern. Med. 2002, 41:254-264.
4. Schindler T., Bornmann W., Pellicena P., Miller W.T., Clarkson B., Kuriyan J. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science 2000, 289:1938-1942.
5. Buchdunger E., Cioffi C.L., Law N., Stover D., Ohno-Jones S., Druker B.J., Lydon N.B. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther. 2000, 295:139-145.
6. Szczepek W.J., Kosmacińska B., Bielejewska A., Łuniewski W., Skarzyński M., Rozmarynowska D. Identification of imatinib mesylate degradation products obtained under stress conditions. J. Pharm. Biomed. Anal. 2007, 43:1682-1691.
7. Solassol I., Bressolle F., Philibert L., Charasson V., Astre C., Pinguet F. Liquid chromatography-electrospray mass spectrometry determination of imatinib and its main metabolite, N-desmethyl-imatinib in human plasma. J. Liq. Chromatogr. Relat. Technol. 2006, 29:2957-2974.
8. Dziadosz M., Bartels H. Imatinib quantification in human serum for clinical purposes using high-performance liquid chromatography with a diode array detector. Acta Chim. Slov. 2011, 58:347-350.
9. Oostendorp R.L., Beijnen J.H., Schellens J.H., Tellingen O. Determination of imatinib mesylate and its main metabolite (CGP74588) in human plasma and murine specimens by ion-pairing reversed-phase high-performance liquid chromatography. Biomed. Chromatogr. 2007, 21:747-754.
10. Teoh M., Narayanan P., Moo K.S., Radhakrisman S., Pillappan R., Bukhari N.I., Segarra I. HPLC determination of imatinib in plasma and tissues after multiple oral dose administration to mice. Pak. J. Pharm. Sci. 2010, 23:35-41.
11. Miura M., Takahashi N., Sawada K. Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection. J. Chromatogr. Sci. 2011, 49:412-415.
12. Davies A., Hayes A.K., Knight K., Watmough S.J., Pirmohamed M., Clark R.E. Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography. Leuk. Res. 2010, 34:702-707.
13. Ivanovic D., Medenica M., Jancic B., Malenovic A. Reversed-phase liquid chromatography analysis of imatinib mesylate and impurity product in Glivec capsules. J. Chromatogr. B 2004, 800:253-258.
14. Suntornsuk L. Recent advances of capillary electrophoresis in pharmaceutical analysis. Anal. Bioanal. Chem. 2010, 398:29-52.
15. García-Campaña A.M., Gámiz-Gracia L., Lara F.J., Iruela M.O., Cruces-Blanco C. Applications of capillary electrophoresis to the determination of antibiotics in food and environmental samples. Anal. Bioanal. Chem. 2009, 395:967-986.
16. Robledo V.R., Smyth W.F. The application of CE-MS in the trace analysis of environmental pollutants and food contaminants. Electrophoresis 2009, 30:1647-1660.
17. Anastos N., Barnett N.W., Lewis S.W. Capillary electrophoresis for forensic drug analysis: a review. Talanta 2005, 67:269-279.
18. Thormann W., Lurie I.S., McCord B., Marti U., Cenni B., Malik N. Advances of capillary electrophoresis in clinical and forensic analysis (1999-2000). Electrophoresis 2001, 22:4216-4243.
19. National Pharmacopoeia Committee, Pharmacopoeia of People's Republic of China, 2010 (Part 2, Appendix 35).
20. The United States Pharmacopeial Convention, United States Pharmacopoeia 34-National Formulary 29, 2011, pp. 292-297.
21. The European directorate for the quality of medicines. Eur. Pharm. 2010, 7:77-82.
22. Kil K.E., Ding Y.S., Lin K.S., Alexoff D., Kim S.W., Shea C., Xu Y., Muench L., Fowler J.S. Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec). Nucl. Med. Boil. 2007, 34:153-163.
23. Zhu Z., Zhang L., Marimuthu A., Yang Z. Large-volume sample stacking combined with separation by 2-hydroxypropyl-beta-cyclodextrin for analysis of isoxyzolylpenicillins by capillary electrophoresis. Electrophoresis 2003, 24:3089-3096.
24. Kartsova L.A., Bessonova E.A. Preconcentration techniques in capillary electrophoresis. J. Anal. Chem. 2009, 64:326-337.
25. Lin C.-H., Kaneta T. On-line sample concentration techniques in capillary electrophoresis: velocity gradient techniques and sample concentration techniques for biomolecules. Electrophoresis 2004, 25:4038-4073.
26. Weng Q., Xu G., Yuan K., Tang P. Determination of monoamines in urine by capillary electrophoresis with field-amplified sample stacking and amperometric detection. J. Chromatogr. B 2006, 835:55-61.
27. Yang Y., Boysen R.I., Hearn M.T. Analysis of synthetic peptides by capillary electrophoresis: effect of organic solvent modifiers and variable electrical potentials on separation efficiencies. J. Chromatogr. A 2004, 1043:91-97.
28. Breadmore M.C. Electrokinetic and hydrodynamic injection: making the right choice for capillary electrophoresis. Bioanalysis 2009, 1:889-894.